Clinical Trial Update: Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy [NA]

View source ↗

Summary

A recruiting clinical trial evaluating CH2 Vaginal Gel to promote vaginal health after pelvic radiotherapy in patients with gynecologic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• CH2 Vaginal Gel

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gynecologic Malignancy | NA | Status: RECRUITING